Back to funds

ARCH Venture Management, LLC

Updated 6 days ago

Managed by Arch Venture Management, Llc • Latest filing Q3 2026

Portfolio value
$1.6B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$651.7M
Q1 2026$677.1M
Q2 2026$1.1B
Q3 2026$1.6B

Top holdings

17 positions as of Q3 2026

View filing
?
1.N/A

KARDIGAN INC

Value
$221.9M
Shares
15.04M
% Port
13.75%
P

PARABILIS MEDICINES INC

Value
$207.1M
Shares
6.41M
% Port
12.83%
V

VIR BIOTECHNOLOGY INC

Value
$141.9M
Shares
12.69M
% Port
8.80%
S

SANA BIOTECHNOLOGY INC

Value
$133.7M
Shares
45.86M
% Port
8.29%
S

SEAPORT THERAPEUTICS INC

Value
$127M
Shares
6.29M
% Port
7.87%
R

RAPPORT THERAPEUTICS INC

Value
$125.3M
Shares
3.73M
% Port
7.77%
S

SCHOLAR ROCK HLDG CORP

Value
$113.3M
Shares
2.35M
% Port
7.03%
M

MAZE THERAPEUTICS INC

Value
$112M
Shares
4.12M
% Port
6.94%
B

BEAM THERAPEUTICS INC

Value
$111M
Shares
4.54M
% Port
6.88%
E

ERASCA INC

Value
$104M
Shares
7.09M
% Port
6.44%
M

908 DEVICES INC

Value
$70.6M
Shares
5.73M
% Port
4.38%
P

PRIME MEDICINE INC

Value
$56.5M
Shares
18.49M
% Port
3.50%
L

LYELL IMMUNOPHARMA INC

Value
$31.8M
Shares
3.25M
% Port
1.97%
G

GENERATE BIOMEDICINES INC

Value
$29.2M
Shares
1.94M
% Port
1.81%
N

NEUMORA THERAPEUTICS INC.

Value
$20.2M
Shares
33.85M
% Port
1.25%
?
16.N/A

BOUNDLESS BIO INC

Value
$6.8M
Shares
2.69M
% Port
0.42%
G

GOSSAMER BIO INC

Value
$1.2M
Shares
100.7K
% Port
0.07%

Explore